SCHEMBL23288605

SCHEMBL23288605

N#CB1CCC(CO)(CCO)CC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24188069 0.77 — —
SCHEMBL8623170 0.72 — —
SCHEMBL23288612 0.71 — —
SCHEMBL18023108 0.68 — —
SCHEMBL1129493 0.66 USP2 (0.33) —
SCHEMBL21287215 0.65 — —
SCHEMBL16112710 0.63 EPHX1 (0.33) —
SCHEMBL13404962 0.61 — —
SCHEMBL16424464 0.61 — —
SCHEMBL12535978 0.60 KDM4E (0.38) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022007502-A1 MANUFACTURE OF COMPOUNDS AND COMPOSITIONS FOR INHIBITING SHP2 NOVARTIS AG (CH) 2022-01-13 — — WO disclosed
WO-2021078120-A1 COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF PARASITIC DISEASES NOVARTIS AG (CH) 2021-04-29 — — WO disclosed
Send feedback